Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Julius

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
The British Journal of Ophthalmology|June 10, 2010
The effect of low-density lipoprotein apheresis on ocular microcirculation in patients with hypercholesterolaemia: a pilot studyNaim Terai, Ulrich Julius, Michael Haustein, et al.
Atherosclerosis. Supplements|May 5, 2015
Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniquesSteffi Kopprasch, Stefan R Bornstein, Sybille Bergmann, et al.
Journal of Cardiovascular Development and Disease|July 26, 2020
Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?Ulrich Julius, Solveig Kuss, Sergey Tselmin, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 30, 2022
The development of lipoprotein apheresis in Saxony in the last yearsSolveig Frieda Rosa Kuss, Ulrike Schatz, Sergey Tselmin, et al.
Expert Review of Cardiovascular Therapy|May 31, 2008
Comparison of different LDL apheresis methodsUlrich Julius, Antje Frind, Sergej Tselmin, et al.
Atherosclerosis. Supplements|November 4, 2017
Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI)Steffi Kopprasch, Stefan R Bornstein, Sybille Bergmann, et al.
Atherosclerosis. Supplements|December 11, 2019
Short- and long-term effects of lipoprotein apheresis on plasma hormones in patients with therapy-resistant dyslipidemiaRomy Walther, Ulrich Julius, Sergey Tselmin, et al.
Atherosclerosis. Supplements|February 5, 2010
Acute effects of lipid apheresis on human serum lipidomeSergey Tselmin, Gerd Schmitz, Ulrich Julius, et al.
Journal of Clinical Apheresis|April 25, 2007
Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and LipidfiltrationUlrich Julius, Klaus G Parhofer, Andreas Heibges, et al.
Herz|November 1, 2007
[Severe progression of coronary heart disease in a patient with elevated lipoprotein (a) level in spite of optimal LDL-C decrease]Sabine Fischer, Ulrich Julius, Sybille Bergmann, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
The British Journal of Ophthalmology|June 10, 2010
The effect of low-density lipoprotein apheresis on ocular microcirculation in patients with hypercholesterolaemia: a pilot studyNaim Terai, Ulrich Julius, Michael Haustein, et al.
Atherosclerosis. Supplements|May 5, 2015
Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniquesSteffi Kopprasch, Stefan R Bornstein, Sybille Bergmann, et al.
Journal of Cardiovascular Development and Disease|July 26, 2020
Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?Ulrich Julius, Solveig Kuss, Sergey Tselmin, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 30, 2022
The development of lipoprotein apheresis in Saxony in the last yearsSolveig Frieda Rosa Kuss, Ulrike Schatz, Sergey Tselmin, et al.
Expert Review of Cardiovascular Therapy|May 31, 2008
Comparison of different LDL apheresis methodsUlrich Julius, Antje Frind, Sergej Tselmin, et al.
Atherosclerosis. Supplements|November 4, 2017
Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI)Steffi Kopprasch, Stefan R Bornstein, Sybille Bergmann, et al.
Atherosclerosis. Supplements|December 11, 2019
Short- and long-term effects of lipoprotein apheresis on plasma hormones in patients with therapy-resistant dyslipidemiaRomy Walther, Ulrich Julius, Sergey Tselmin, et al.
Atherosclerosis. Supplements|February 5, 2010
Acute effects of lipid apheresis on human serum lipidomeSergey Tselmin, Gerd Schmitz, Ulrich Julius, et al.
Journal of Clinical Apheresis|April 25, 2007
Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and LipidfiltrationUlrich Julius, Klaus G Parhofer, Andreas Heibges, et al.
Herz|November 1, 2007
[Severe progression of coronary heart disease in a patient with elevated lipoprotein (a) level in spite of optimal LDL-C decrease]Sabine Fischer, Ulrich Julius, Sybille Bergmann, et al.
Pageof 9